Betterchem
Health     Drug Information     DMFs     Portal     21CFR     Search     Site Map

 
This Drug's…

Digests and News Feeds
Access to FDA, drug company, and major news organization databases.


   FDA Drug Thesaurus…


FDA approval activities for this prescription drug:

Oxsoralen-Ultra (methoxsalen), USP, Capsules, 10 mg, ICN NDA 19-600/S-006 & S-009 UVADEX (methosalen) Sterile Solution, 20 mcg/mL, Therakos, NDA 20-969 2/25/99 3/2/99 3/2/99 6/14/99 UVADEX Indication:This new drug application provides for the use of UVADEX® (methoxsalen) Sterile Solution with the UVAR® Photopheresis System in the palliative treatment of the skin manifestations of cutaneous T-cell lymphoma (CTCL) that is unresponsive to other forms of treatment. METHOXSALEN Capsule; 10MG 8-MOP ICN 019600 METHOXSALEN Capsule; 10MG OXSORALEN-ULTRA ICN 020969 METHOXSALEN Injection 0.02MG/ML UVADEX THERAKOS 009048 METHOXSALEN Lotion; Topical 1% OXSORALEN ICN

For the latest approval information, please locate this API using this index.

 
                                                                                  


A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U-Z

Health | Pharma News | DMF Index | Vet Drugs | For Industry

© 2009 Betterchem.com